Search clinical trials for: VELCADE TM (bortezomib) for Injection, or PS-341
Total 125 results
-
Millennium Pharmaceuticals, Inc.TerminatedAdvanced Non-Small Cell Lung Cancer | Other Solid Tumors
-
Millennium Pharmaceuticals, Inc.CompletedColorectal CarcinomaUnited States
-
Millennium Pharmaceuticals, Inc.CompletedNon-Small Cell Lung CancerUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedLeukemia | Chronic Myeloproliferative DisordersUnited States
-
M.D. Anderson Cancer CenterMillennium Pharmaceuticals, Inc.CompletedLeukemiaUnited States
-
Baylor College of MedicineMillennium Pharmaceuticals, Inc.CompletedProstate NeoplasmsUnited States
-
M.D. Anderson Cancer CenterMillennium Pharmaceuticals, Inc.CompletedLymphoma, B-CellUnited States
-
M.D. Anderson Cancer CenterMillennium Pharmaceuticals, Inc.CompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerUnited States
-
Rasim GucalpMillennium Pharmaceuticals, Inc.TerminatedNon-small Cell Lung CancerUnited States
-
M.D. Anderson Cancer CenterCompletedMultiple MyelomaUnited States
-
Millennium Pharmaceuticals, Inc.CompletedMantle Cell LymphomaUnited States
-
Millennium Pharmaceuticals, Inc.CompletedProstatic NeoplasmsUnited States
-
Beijing Chao Yang HospitalEnrolling by invitationMultiple Myeloma | BortezomibChina
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedGraft-versus-Host DiseaseUnited States
-
Children's Hospital Medical Center, CincinnatiCompletedAllogeneic Stem Cell Transplantation | Refractory Autoimmune Cytopenia(s)United States
-
Mayo ClinicCompletedRefractory Multiple MyelomaUnited States
-
Jules Bordet InstituteCompletedCarcinoma Breast Stage IVBelgium
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.TerminatedMultiple MyelomaUnited States
-
National Cancer Institute (NCI)CompletedHead and Neck Cancer | Laryngeal Cancer | Oral Cancer | Carcinoma, Squamous | Pharyngeal CancerUnited States
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)CompletedLymphoma | LeukemiaUnited States
-
Northwestern UniversityRobert H. Lurie Cancer CenterCompletedNon-Hodgkin's LymphomaUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)TerminatedMelanoma | Solid Tumor | Brain and Central Nervous System TumorsUnited States
-
National Cancer Institute (NCI)CompletedSarcoma | Lymphoma | Neuroblastoma | WilmsTumorUnited States
-
M.D. Anderson Cancer CenterCompleted
-
University of Southern CaliforniaMillennium Pharmaceuticals, Inc.CompletedProstate CancerUnited States
-
M.D. Anderson Cancer CenterMerck Sharp & Dohme LLCTerminated
-
Ohio State University Comprehensive Cancer CenterCompletedNon-Hodgkin's Lymphoma | Mantle Cell LymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.CompletedProstate CancerUnited States
-
M.D. Anderson Cancer CenterMillennium Pharmaceuticals, Inc.Active, not recruitingWaldenstrom's MacroglobulinemiaUnited States
-
Milton S. Hershey Medical CenterSanofiTerminatedNon Small Cell Lung CancerUnited States
-
University of Wisconsin, MadisonNational Cancer Institute (NCI); Pfizer; Millennium Pharmaceuticals, Inc.CompletedNon-Hodgkins LymphomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Adult Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Recurrent Disease | Recurrent Adult Acute Lymphoblastic Leukemia | Adult Acute Monoblastic Leukemia | Adult Acute Monocytic Leukemia | Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 | Adult Acute Myeloid... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedHIV Infection | Recurrent Kaposi Sarcoma | AIDS-Related Kaposi SarcomaUnited States
-
Dana-Farber Cancer InstituteNovartis; Millennium Pharmaceuticals, Inc.TerminatedWaldenstrom's MacroglobulinemiaUnited States
-
City of Hope Medical CenterCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Pierluigi PorcuMillennium Pharmaceuticals, Inc.; Celgene CorporationCompletedPeripheral T-cell Lymphoma | Anaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Adult Nasal Type Extranodal NK/T-cell Lymphoma | Hepatosplenic T-cell Lymphoma | Post-transplant Lymphoproliferative Disorder | Recurrent Adult T-cell Leukemia/Lymphoma | Recurrent Cutaneous T-cell... and other conditionsUnited States
-
M.D. Anderson Cancer CenterCompletedLymphoma | Solid Tumors | Myeloma | Advanced MalignancyUnited States
-
M.D. Anderson Cancer CenterGenentech, Inc.; Millennium Pharmaceuticals, Inc.Withdrawn
-
M.D. Anderson Cancer CenterMillennium Pharmaceuticals, Inc.Active, not recruitingSolid Tumor | Urethral CancerUnited States
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Myelodysplastic Syndrome | Acute Lymphocytic Leukemia | Chronic Myelogenous LeukemiaUnited States
-
University of California, DavisNational Cancer Institute (NCI)CompletedLung Cancer | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Washington University School of MedicineMillennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
Northwestern UniversityEli Lilly and Company; Millennium Pharmaceuticals, Inc.Terminated
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Leukemia | Breast Cancer | Ovarian Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
M.D. Anderson Cancer CenterCephalonCompleted
-
National Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Therapy-Related Acute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterMillennium Pharmaceuticals, Inc.CompletedLymphoma | Hodgkin LymphomaUnited States
-
M.D. Anderson Cancer CenterCompleted
-
National Cancer Institute (NCI)Active, not recruitingAcute Myeloid Leukemia | Recurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Acute Myeloid Leukemia Post Cytotoxic TherapyUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedDS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States